Israel’s Sequentify (see here previously) was awarded a grant by the Israel Innovation Authority to help develop a targeted DNA sequencing panel for infectious disease research, focusing on pathogen diagnosis and antibiotic resistance surveillance. https://www.prnewswire.com/news-releases/sequentify-awarded-grant-by-israel-innovation-authority-for-infectious-disease-sequencing-panel-302031466.html

Stanford Institute for Stem Cell Biology and Regenerative Medicine is to using the AML(acute myeloid leukemia) detection kits from Israel’s Sequentify (see here previously) in its leukemia research. Sequentify’s Infiniseq technology cuts DNA sequencing time to only 3.5 hours. https://www.prnewswire.com/il/news-releases/stanford-to-use-sequentify-kits-for-hematological-malignancies-ngs-sequencing-301981511.html

Israel’s Sequentify, a spinoff of Israel’s Weizmann Institute, enables fast and focused DNA sequencing, by combining tools from synthetic biology and artificial intelligence. Its Next Generation Sequencing (NGS) products include Covid-19 surveillance, cancer diagnostics, carrier screening and more. https://www.calcalistech.com/ctechnews/article/bjemsap8c https://www.sequentify.com/